Trial
NCT03985423
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Swedish Orphan Biovitrum
Collaborators
Light Chain Bioscience - Novimmune SA
Condition
Hemophagocytic Lymphohistiocytoses
Intervention
Emapalumab-Lzsg
Why stopped
Sponsor Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-06